Mechlorethamine Hydrochloride, also known as nitrogen mustard, is a chemotherapeutic agent primarily used in the treatment of certain types of
cancer. Understanding its mechanism of action is crucial for comprehending its therapeutic effects and potential side effects.
Mechlorethamine Hydrochloride belongs to a class of drugs called alkylating agents. These agents are characterized by their ability to add an alkyl group (CnH2n+1) to DNA. The alkylation process occurs at the N7 position of guanine in the DNA molecule, resulting in the formation of cross-links between DNA strands or within the same strand. This cross-linking disrupts the normal function of DNA, which can lead to the inhibition of DNA replication and transcription.
The primary mechanism through which Mechlorethamine Hydrochloride exerts its effects is through the formation of covalent bonds with DNA. Once inside the cell, Mechlorethamine Hydrochloride undergoes a chemical reaction that converts it into a highly reactive ethylenimonium ion. This ion is the active form of the drug and is responsible for interacting with the DNA. The ethylenimonium ion reacts with the nitrogen and oxygen atoms in the bases of DNA, most notably guanine. This reaction results in the formation of intra- and inter-strand DNA cross-links, which ultimately impede the DNA's ability to unwind and separate—an essential step for replication and transcription.
The disruption of DNA synthesis and function triggers a cascade of cellular events leading to cell cycle arrest. Specifically, cells are halted at the G2/M phase, where DNA damage checkpoints prevent the cell from entering mitosis with damaged DNA. If the DNA damage is irreparable, the cell undergoes apoptosis, or programmed cell death. This apoptotic effect contributes to the reduction of the tumor mass, as cancer cells are particularly susceptible to DNA damage due to their high rate of division.
It is important to note that while Mechlorethamine Hydrochloride is effective in targeting rapidly dividing cancer cells, it is not selective and can also affect normal cells that divide quickly. This lack of specificity can result in side effects such as
myelosuppression, gastrointestinal disturbances, and mucosal damage. These side effects underscore the importance of precise dosing and administration under medical supervision.
In addition to its role in cancer therapy, Mechlorethamine Hydrochloride has a historical significance as it was one of the first chemotherapeutic agents discovered. Its development marked the beginning of modern chemotherapy and has paved the way for the development of numerous other alkylating agents and cancer treatments.
In conclusion, Mechlorethamine Hydrochloride functions primarily by alkylating DNA, resulting in the formation of cross-links that disrupt DNA replication and transcription. This leads to cell cycle arrest and apoptosis, particularly in rapidly dividing cells. Despite its effectiveness, its lack of selectivity necessitates careful administration to manage potential side effects.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


